Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Gyre Therapeutics (GYRE) Receivables - Other (2023 - 2026)

Gyre Therapeutics has reported Receivables - Other over the past 6 years, most recently at $230000.0 for Q4 2025.

  • Quarterly Receivables - Other changed 0.0% to $230000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $230000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $230000.0 for FY2025, 0.0% changed from the prior year.
  • Receivables - Other was $230000.0 for Q4 2025 at Gyre Therapeutics, up from $200000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $1.3 million in Q3 2024 and troughed at $200000.0 in Q1 2025.
  • The 3-year median for Receivables - Other is $300000.0 (2023), against an average of $569090.9.
  • Year-over-year, Receivables - Other skyrocketed 166.67% in 2024 and then crashed 84.62% in 2025.
  • A 3-year view of Receivables - Other shows it stood at $800000.0 in 2023, then plummeted by 71.25% to $230000.0 in 2024, then changed by 0.0% to $230000.0 in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Receivables - Other are $230000.0 (Q4 2025), $200000.0 (Q3 2025), and $200000.0 (Q2 2025).